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Summary Since biomaterials contact many different tissues, those materials must have
optimum surface compatibility with the host bone tissue and soft tissue, as well as anti-microbial
properties on an exposed region of the mucosa. Such materials can be created under well-
controlled conditions by modifying the surfaces of materials that contact those tissues. This paper
is focused on the surface modification of biomaterials for developing ‘‘Bio-functional dental
implants’’, which are compatible with all host tissues, using a cold-plasma technique.
At the bone tissue/implant interface, a thin calcium phosphate coating and rapid heating with
infrared radiation were effective in controlling the dissolution without cracking the coating. These
thin calcium phosphate coatings may directly promote osteogenisis, but also enable immobilization
and subsequent drug delivery system (DDS) of bisphosphonates. Simvastatin is also an effective
candidate that is reported to increase the expression of BMP-2. The thin-film of hexamethyldisi-
loxane (HMDSO) was plasma-polymerized onto titanium, and then HMDSO surface was activated by
O2-plasma treatment. A quartz crystal microbalance (QCM-D) technique demonstrated that
simvastatin was immobilized on the plasma-treated surfaces due to introduction of O2-functional
groups. At the soft tissue/implant interface, multi-grooved surface topographies and utilizing the
adhesive proteins such as fibronectin or laminin-5 may help in providing a biological seal around the
implant. At the oral fluid/implant interface, an alumina coating, F+-implantation and immobiliza-
tion of anti-microbial peptides were responsible for inhibiting the biofilm accumulation.
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The vital reaction of biomaterials is affected by the ‘‘surface
topography’’ and ‘‘surface physico-chemistry’’ of the mate-
rials. Surface topography has marked effects on cell beha-
vior. Generally, cell adhesion is greater on rough surfaces
than on smooth surfaces, but the actual rate of adhesion
depends on the type of cell. Contact guidance, the phenom-
enon in which cells align along grooves of the substrate, is one
example of surface topography controlling cell behavior
[1,2]. Surface roughness alters osteoblast proliferation, dif-
ferentiation, and matrix production in vitro, and plays a role
in determining the phenotypic expression of cells in vivo
[3,4]. Surface topography is controlled by machining, blast-
ing, acid etching, or laser lithography.
Surface physico-chemistry involves the adsorption of pro-
teins, bacteria, and cells on biomaterials. This adsorption
reflects the affinity between two substances. Adsorption
characteristics are primarily influenced by hydrophobicity
(wettability), which can be determined by measuring the
surface energy (hydropathy index), and electrokinetic poten-
tial (zeta potential, isoelectric point), which reflects surface
electric charges according to the isoelectric point (x-axis in
Fig. 1) and hydropathy index (y-axis in Fig. 1) of the amino
acids in the protein (Fig. 1).
A cold plasma-surface modification (Fig. 2) is suitable for
change in surface physico-chemistry, which involves dry
process including ion implantation, ion plating, ion sputter-Figure 1 Isoelectric point (x-axis) and hydropathy index (y-
axis) of amino acids.ing, ion beam dynamic mixing, plasma polymerization and
plasma treatment with partly ionized gases, which is gener-
ated in a high-voltage electric field in a low pressure. This
approach is superior in that it is environmentally pollution-
free, it yields safe products, and good quality control can be
maintained, thus ensuring defect-free films. In this process,
substrates and targets are placed in a vacuum chamber, a
vacuum is created and the coating materials are then depos-
ited onto the substrates in a cold plasma atmosphere.
Fig. 3 shows the relationship between film thickness and
energy of atoms, which is related to adherence of coatings, in
various coatings produced by ion beam techniques. It can be
seen that the thinner the coatings, the higher the degree of
adherence. Surface modification using a cold plasma has
advantages; 1) Thin and porosity-free coatings, 2) Control
of surface energy and surface electric charge, 3) Introduction
of functional groups, 4) Cleaning of surfaces, 5) Graft-poly-
merization and adhesion, 6) Etching and micro-patterning
and 7) Application for drug delivery system.
This review will describe the surface modification of
titanium implant for bio-functionalization (Fig. 4) [5] related
to the surface topography and physico-chemistry of different
host tissues.
Bone tissue/Implant interface
The integration of bone tissue with an implant requires a
rough surface topography that maximizes the area in contact
with the bone and allows the contact guidance for the
development of osteoblasts. As for surface physico-chemis-
try, surface modification with a thin calcium phosphate coat-
ing is useful in producing rapid osteogenesis and strong
osseointegration. There have been also attempts to employ
drugs such as bisphosphonate and simvastatin, which induce
osteogenesis more efficiently.
Thin calcium phosphate (CaP) coating
CaP implants, including hydroxyapatite (HAp), are well
known for good osteoconductivity (the early stage of osteo-
genesis) as well as for direct binding to bone tissue in vivo.
Alkaline phosphatase expression and parathyroid hormone
response were higher in cultures grown in HAp than in
cultures grown in titanium [6], and the in vitro formation
of extracellular matrices was greater on CaP coatings than on
titanium. Several mechanisms of the principal factors
involved in osteogenesis on CaP ceramics have been consid-
ered. First, implanted CaP (HAp) acts as a nucleation site and
Figure 2 Schematics of surface modification using a cold-plasma.
Surface modification using cold-plasma technique 91exhibits crystallographic properties in an epitaxial process of
the newly developed structure. The calcium ions dissolve
from the CaP surface, resulting in the deposition of a miner-
alized layer. This stimulates the bone cells to continue
extracellular matrix (bonding zone) synthesis and calcifica-
tion [7]. CaP ceramics adsorb many osteo-conductive and/or
osteo-inductive proteins, which have an important role in the
mineralization of bone tissues.
In spite of their rapid and strong bonds to living bone
tissues and favorable osteogenic ability, CaP ceramics alone
cannot be used for implants because of their lack of strength.
Accordingly, CaP coatings on Ti implants produced by the
plasma spraying have frequently been used [8]. These CaP
coated implants, however, often develop fractures in their
coatings as well as at the titanium interface after implanta-
tion. The reason for this is thought to originate in theFigure 3 Relationship between film thickness and energy of
atoms, which is related to adherence of coatings.comparatively thick, porous, non-uniform (crystalline sur-
rounded by an amorphous mass), and poorly adherent CaP
layer produced by plasma spraying (Fig. 5). These fragments
of a certain size cause phagocytosis by macrophages, leading
to inflammation. It is therefore desirable for the materials to
be rapidly and completely absorbed in the host tissues and to
be entirely replaced with bone tissue. When osteogenesis
occurs at the site where old bones are absorbed (remodeling
of bones), the CaP coatings should be no thicker than neces-
sary.
Attempts have recently been made to solve problems in
the plasma spraying technique using a cold-plasma surface
modification as above-mentioned [9]. In the cold plasma, ion-
plating [10] and the ion sputtering [11], which are a kind of
physical vapor deposition (PVD), are used to produce implant
materials consisting of a thin, homogeneous, and adherent
CaP coating. Ion beam dynamic mixing (IBDM) was alsoFigure 4 Bio-functionalization of dental implants with surface
modification.
Figure 5 CaP coatings produced by plasma spraying method:
Scanning electron micrograph (SEM) of cross section (a), and
optical micrograph of surface after soaking in 0.9% NaCl solution
at pH 6.0 for 30 weeks (b).
92 M. Yoshinari et al.introduced as a suitable technique for fabricating a thin and
adherent ceramic layer [12]. This method is a combination of
ion implantation and PVD, and has the advantages of a high
deposition rate, producing defect-free transparent thin
films, and excellent adhesion compared to conventional
thin-film deposition techniques.
Fig. 6 shows a commercially available Bra˚nemark implant
and a CaP coated implant. The slight color change is recog-
nized in the coated implant due to the thin (1 mm) and
defect-free coating. Good degrees of osteogenesis and bond
strength with bone are obtained in the thin CaP coated
implants [13].
Although as-deposited coatings were confirmed to be
amorphous by thin X-ray diffraction (XRD) analysis, post-
deposition heat treatment was reported to result in a change
in crystallinity [9,11,14—19]. The diffraction pattern of heat-Figure 6 (a) Bra˚nemark implant (left) and CaP coated implant
by IBDM method; (b) SEM images of cross section of CaP coatings
produced by IBDM; (c) SEM images of IP coatings after bending
test; lower image in b and c show higher magnification of area
shown in rectangle in upper micrograph (Yoshinari et al. [10]).treated coatings showed mainly HAp, with a preferential
orientation of the c-axis (0 0 2) (Fig. 7) [17]. Fourier trans-
formation infrared (FT-IR) spectrometry analysis has
revealed absorption of OH and PO4
3 in both as-deposited
and heat-treated coatings [18]. The binding energies of P2p,
Ca2p3/2 and O1 s obtained from coated specimens were
close to those of HAp bulk, according to X-ray photoelectron
spectroscopy (XPS) [11].
Change in bond strength and solubility by heat
treatment
The tensile bond strength of as-deposited coatings to Ti
substrates has been reported to be 38—45 MPa with ion beam
sputter deposition [20], more than 53 MPa with magnetron
sputtering [10] and in excess of 59 MPa with IBDM [11]. Thus,
thin CaP coatings produced by a cold plasma system demon-
strate high bond strength to Ti substrates, as they have fewer
defects than, and offer superior adhesion to, those produced
by conventional plasma spraying methods.
Unfortunately, as-deposited coatings are amorphous
(Fig. 7a), resulting in films that easily dissolve in body fluids
[17]. This renders them inappropriate for biomedical use. As-Figure 7 Thin XRD profiles of as-deposited (a), furnace-heated
at 500 8C for 4 h (b), rapid heating with infrared radiation at
500 8C (c) and 700 8C (d), and HAp powder as evaporant for
coating (e) (Yoshinari et al. [18]).
Figure 8 SEM of coatings by rapid heating with infrared radia-
tion at 400 8C (a), 600 8C (b), and 800 8C (c) after immersion in
SBF for 35 days. Lower images in a, b, c show higher magnifica-
tion of area shown in rectangle in upper micrograph (Yoshinari
et al. [18]).
Surface modification using cold-plasma technique 93deposited coatings crystallize during heat treatment using a
conventional electric furnace (Fig. 7b), leading to decreased
solubility [13,14,17,19]. Such coatings, however, tend to
crack easily, resulting in a reduction in bond strength [13],
especially after soaking in body fluid [11,17]. Therefore, a
suitable heat treatment is required that will offer control of
the solubility of the CaP coating without weakening its
adhesion to the Ti substrate.
It has been reported that rapid, homogeneous, and com-
paratively low-temperature heating at 600—700 8C such as
defocused infrared radiation allows control of CaP solubility
and ensures adherence of coatings for both ion-sputtering (IS)
and IBDM [17,18]. In rapid-heating with infrared radiation at
400 8C (Fig. 8a), the coatings disappeared and many preci-
pitates appeared on the Ti substrate after immersion in SBF.
No apparent change was observed in the coatings rapidly
heated at 600 8C due to limited dissolution of coatings
(Fig. 8b). However, many cracks were observed on the coat-
ings rapidly heated at 800 8C (Fig. 8c).
Fig. 9 shows change in film thickness of IBDM-coatings
relative to approximately 1.0 mm as-deposited coatings in
SBF. The coatings on the as-deposited specimens (As) almost
completely disappeared after 1 day. Furnace-heated coatings
(HV) decreased in thickness depending on length of time ofFigure 9 Change in film thickness of coatings relative to as-
deposited thickness of approximately 1.0 mm in SBF (Yoshinari
et al. [18]).immersion, and the standard deviation is greater than the
measured value after 5 weeks of immersion which may have
been caused by partial peeling of the coatings. The coatings
rapidly heated with infrared radiation at 400 8C (IR400)
almost disappeared after 1 week, whereas those of IR600
and IR800 retained approximately 60% and 55% of their
thickness, respectively, after 5 weeks of immersion. This
tendency is believed to be correlated with the crystallinity
of the coatings. The IR800 specimens, however, showed large
standard deviations after 1 week and 5 weeks of immersion
due to partial peeling of coatings.
Table 1 shows change in tensile bond strength between
coatings and Ti substrate after immersion in SBF [11,17]. The
times until the maximum temperature was reached were
approximately 8, 10, 13, and 26 s for IR400, IR500, IR600, and
IR800, respectively. Table 1 also shows change in surface
morphology with dissolution or cracking of the coatings. As-
deposited coatings and rapid-heated coatings at 400 8C with
infrared radiation dissolved within a couple of days. Cracks
were observed in the coatings with furnace heating at 500 8C
for one hour and rapid heating at 800 8C. Rapid heating at 600
and 700 8C yielded high bond strength. These results indicate
that high temperatures and long duration are unnecessary in
obtaining crystallinity in thin coatings.
Dissolution of coated film and/or precipitation of calcium
phosphate from the solution on the surface appear to occur
simultaneously. With HAp, the SBF solution is supersaturated
with Ca and P, so precipitation should be the major reaction if
HAp is crystallized completely. However, dissolution is often
observed in CaP coatings. Dissolution is dependent on the
crystallinity, grain size, and density of CaP films. Low crystal-
linity, small grain size, lower density and the presence of
impurities such as CO3 give higher solubility [21,8,22—24].
Mechanism for debonding of CaP coatings
Reduction in bond strength is observed in heat-treated speci-
mens. This appears to be a result of internal stresses caused
by change in film density and the formation of titanium oxides
and Ti—P compounds due to diffusion of elements. This exerts
an adverse influence on the bond between the CaP coating
and the Ti substrate [19].Table 1 Change in bond strength (MPa) between coatings
and Ti substrate after immersion in SBF for 35 days. Tensile
bond strength was measured in specimens showing no change
in surface morphology.
Before
immersion
After
immersion
As-deposited 59.0 (10.5) Dissolved
Furnace heated at
500 8C for 1 h
46.3 (17.0) Cracked
Infrared radiation
(rapid heating)
400 8C 59.6 (13.0) * Dissolved
500 8C 55.7 (6.9) * Peeled partially
600 8C 60.2 (13.8) * 44.9 (9.6)
700 8C 57.8 (9.6) * 48.4 (11.7)
800 8C 33.5 (15.4) Cracked
Figure 10 (a) XPS depth profiles of Ti substrates in which Ca—P
coatings were removed by epoxy glue, (b) diffusion of P and Ca,
and creation of many Ti—P compounds at the interface that leads
to debonding of CaP coating if too much thermal energy is
applied to CaP-coated titanium (Yoshinari et al. [18]).
Figure 11 Possible structure of immobilization of bisphospho-
nates (Pamidronate disodium) to titanium through thin Ca—P
coatings.
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mechanism at the CaP coating/Ti interface after heat-treat-
ment has been revealed [17]. The results of XPS analyses of
the interface between the coating and the Ti substrate
(depth profile of Ti substrates, in which CaP coatings were
removed by epoxy glue) are shown in Fig. 10a. The intensities
of the P3 states (Ti3P4) of the furnace-heated and 800 8C
rapid-heated specimens were larger than those of as-depos-
ited or 600 8C rapid-heated specimens, and the intensities of
the Ca2p spectrum decreased in the furnace-heated and
800 8C rapid-heated specimens. In addition, no remarkable
differences in Ti-oxidation state (TiO2) were observed among
the specimens. These results suggest that too much growth of
Ti—P compounds and decreased thickness of Ca-implanted
layers is a major reason for cracks due to debonding of
coatings. According to the binary phase diagram, the Ti—
Ca system has neither solid solutions nor intermetallic com-
pounds. In contrast, the Ti—P system has many intermetallic
compounds such as Ti3P4, Ti3P, Ti5P3 and Ti2P. Therefore, if
too much thermal energy is applied to CaP coated titanium, P
diffuses toward the Ti substrate creating many Ti—P com-
pounds at the interface, which results in cracks in the coat-
ings due to debonding, and the Ca diffuses out of the Ti
substrate (Fig. 10b). Titanium oxide is not considered to play
a dominant role in bonding between thin CaP coatings and Ti
substrates.
Immobilization of bisphosphonates and
simvastatin
Immobilization of osteogenesis-promoting drugs on thin CaP
coatings is a promising new approach to achieve rapid
osseointegration and improvement in the bone bed at the
bone tissue/implant interface. In the treatment of osteo-
porosis, bisphosphonates and simvastatins have been
reported to stimulate bone formation [25] and increase
expression of BMP-2, respectively [26].Bisphosphonates work not only as potent inhibitors of
osteoclastic bone resorption but also exert a direct effect
on osteoblasts [27]. It was reported that bisphosphonates
were able to immobilize on titanium implants through thin
CaP coatings [28—30]. The reason for this may be their
marked affinity to calcium phosphates. XPS and FT-IR ana-
lyses revealed that titanium surfaces modified with thin CaP
coatings allowed immobilization of bisphosphonate, and that
such surfaces revealed physiologically active functional
groups of bisphosphonate origin (Fig. 11). Alkaline phospha-
tase expression activity and bone-like nodule formation in rat
bone marrow cells showed a greater increase on plates with
immobilized bisphosphonate than on as-received titanium,
indicating that bisphosphonate-immobilization has no toxic
effect on osteoblasts, and that it provides a favorable micro-
environment conducive to osteogenesis [28,31]. In an in vivo
test using beagle dogs, fluorescence was widely observed in
newly formed bone tissue around bisphosphonate-immobi-
lized implants, and the ratio of bone contact to the bispho-
sphonate-immobilized implants was significantly higher than
in other implants at twelve weeks [29]. In addition, confocal
laser scanning microscopy revealed that new bone widths
significantly increased around bisphosphonate-immobilized
implants compared with pure titanium implants [30]
(Fig. 12). These results suggest that thin CaP coatings on
titanium surfaces enable immobilization of bisphosphonates,
and that bisphosphonate-immobilized surfaces promote
osteogenesis around medical implants. In addition, the con-
centration of released bisphosphonates can be controlled by
regulating the crystallinity of HAp coatings as a carrier [32].
On the simvastatin (SV), since only the open-ring or beta-
hydroxy acid forms (SVA) exhibit the efficacy of this medica-
tion for topical application, SV should be hydrolyzed to SVA.
Accordingly, immobilization of SVA onto dental implants is
expected to promote osteogenesis around dental implants.
Thin-film of hexamethyldisiloxane {HMDSO, (CH3)3SiO-
Si(CH3)3} was plasma-polymerized onto titanium, then
HMDSO surfaces were activated by O2-plasma treatment
[33,34], resulting that hydroxyl group or O2-functional groups
Figure 12 Confocal laser scanning microscopy (upper, Cal: calcein (1 week), Alc: alizarin complexone (3 weeks) and new bone width
of Ti and Bisphosphonate-immobilized implants in wistar rats (lower) Imp: implant, NB: new bone (Kajiwara et al. [30]).
Figure 13 XPS spectra of Ti, Ti + O2, HMDSO, and HMDSO + O2 specimens (HMDSO: hexamethyldisiloxane, O2: O2-plasma treatment)
(Yoshinari et al. [33]).
Surface modification using cold-plasma technique 95were introduced to immobilize the SVA (Fig. 13). Adsorption
assay of SVA using a quartz crystal microbalance-dissipation
(QCM-D) instrument demonstrated the largest amount of SVA
was adsorbed on O2-plasma treated HMDSO surfaces com-
pared to untreated titanium, HMDSO-coated titanium, and
O2-plasma treated titanium. These findings suggested that
the adsorption of SVA was enhanced on more hydrophilic
surfaces concomitant with the presence of an OH group
and/or O2-functional group resulting from the O2-plasma
treatment (Fig. 14), and that an organic film of HMDSOfollowed by O2-plasma treatment is a promising method
for the adsorption of SVA in dental implant systems.
Controlled release of SVA by means of its topical applica-
tion around dental and maxillofacial implants would promote
osteogenesis in surrounding bone tissue. Because of their
multi-functional characteristics and bioadaptability, cyclo-
dextrins (CDs) are capable of forming inclusion complexes
with many drugs by including a whole drug molecule inside
their cavity (Fig. 15). The SVA release properties from SVA/CD
coatings with different pH values were evaluated as well as
Figure 14 Possible structure change of HMDSO monomers (a) by
plasma polymerization (b), following O2-plasma treatment (c),
and immobilization mechanism of SVA (d) (Yoshinari et al. [33]).
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96 M. Yoshinari et al.the characteristics of the coatings [35]. The results showed
that the number of SVA/CD complexes formed depended on
the pH of the solution, and that subsequent release of SVA
from the coatings depended on the number of complexes and
resulting crystallinity of the coatings (Fig. 16). These results
suggest that SVA/CD complexes offer potential in bone gen-
eration with a drug delivery system around dental and max-
illofacial implants.
Soft tissue/Implant interface
Dental implants lack the structures that maintain the con-
tinuity between the epithelium and connective tissues that
are normally formed by hemidesmosomes and the basalFigure 15 Chemical structure (upper) and toroidal shape
(lower) of b-cyclodextrin molecule (Yoshinari et al. [35]).lamina, which connect dental enamel and adhesive epithe-
lium. Peri-implant epithelium has a reduced capacity to act
as a proliferative defense mechanism than does the junc-
tional epithelium [36,37]. Therefore, to prevent the invasion
of the bacteria and epithelium, a system of biological sealing
is required. We found that the extension and spread of
fibroblasts and epithelial cells were critically influenced by
the pore diameter of 1.2—3.0 mm in Millipore filters. Our
observation of in vitro experiments also suggests that a range
in hole size of 50—100 mm is most critical for the connective
tissue cells to migrate and orient at right angles to the
implant surface, similar to Sharpey’s fibers. Multi-grooves,
a combination macro-grooves and micro-grooves, are also
considered to be useful for ECM production with a contact
guidance [38] (Fig. 17). These surface topographies may help
in providing a biological seal around the implant.Figure 17 Multi-grooves, a combination of macro-grooves
(approximately 50 mm) and micro-grooves (approximately
1 mm), to control the orientation of both cells and extracellular
matrix (ECM) such as collagen.
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ing the titanium surface using adhesive proteins such as
fibronectin or laminin-5 compatible with the soft tissue/
implant interface have been proposed. For the implant sur-
face in contact with subepithelial connective tissues, tresyl
chloride treatment is used to adhere the selected proteins
such as fibronectin to the amino residues [39]. The gingival
epithelium attached to dental implants through the forma-
tion of hemidesmosomes using laminin-5 [40]. A stable coat-
ing and prevention of protein denaturation at the time of
implantation are necessary.
Oral fluid/Implant interface
Microbial plaque accumulation surrounding dental implants
may develop into peri-implantitis, which is defined as inflam-
mation or infection around an implant, with accompanying
bone loss. Biofilm accumulations are observed surrounding
titanium implants, and many kinds of bacteria, which were
confirmed to be the same as periodontopathic bacteria [41],
are recognized in the biofilm formation (Fig. 18).Figure 18 X-ray photograph around peri-implantitis (black
arrows, upper) and microbial plaque accumulation surrounding
the abutment of dental implants (lower).It is therefore important to maintain the surface of dental
implants exposed to the oral cavity (Oral fluid/Implant inter-
face) free of biofilm to prevent peri-implantitis. There are at
least two methods of inhibiting the formation of microbial
plaque. The first is to inhibit the initial adhesion of oral
bacteria. The second is to inhibit the colonization of oral
bacteria, which involves surface antimicrobial activity. The
adhesion of bacteria is greatly influenced by electric charges
on the implant surface because bacteria have a large specific
surface area. Antimicrobial modification can be effective for
the implant surface. Another requirement for the modified
surfaces is their resistance to wear when the teeth are
brushed.
Initial adhesion of oral bacteria
The initial adherence of oral bacteria on cp-titanium and
titanium surfaces modified with a cold-plasma was investi-
gated [42] (Table 2). Surface modifications were conducted
with cold plasmas that included ion implantation (Ca+, N+,
F+), oxidation (titania spraying), ion plating (TiN, alumina),
and ion beam mixing (Ag, Sn, Zn, Pt) with Ar+ on polished pure
titanium plates. The results showed that comparatively large
amounts of P. gingivalis and A. actinomycetemcomitans,
which are major periodontopathic bacteria, adhered to
polished cp-titanium. These findings indicate that there is
a probable risk of bacterial adhesion to titanium surfaces at
the supra- and sub-gingival portions of implants, and surface
modification to inhibit the adherence of oral bacteria is
required. The degree of P. gingivalis adhesion showed a
positive correlation with surface energy and the amount of
calcium-ion adsorption.
The level of bacterial adhesion on calcium-implanted
surfaces was greater than on polished titanium, despite
similar degrees of surface roughness. The reason for this is
believed to be that the Ca-rich surfaces on the calcium-
implanted specimens promoted protein adsorption in saliva
and, ultimately, bacterial adhesion. Accordingly, even
though calcium-ion implantation is beneficial in bonding
implants to bone tissue, this treatment carries with it the
risk of promoting the adhesion of biofilm on surfaces exposed
to the oral cavity. In contrast, the level of initial adhesion of
bacteria decreased on the alumina-coated specimen. This is
related to the nonadsorption of calcium ions on alumina-
coated specimens. In contrast to titanium oxide, the iso-
electric point of a-A12O3 is reported to be 9.2 and that of g-
A12O3 is reported to be 8.0. Therefore, the surface of the
alumina-coated specimen is considered to be positively
charged, and calcium ions were not adsorbed on the surface,
resulting in a decrease in the initial levels of adhered P.
gingivalis.
Antibmicrobial activity
Antimicrobial activity was also investigated on the same
specimens as the initial adhesion assay [43]. F+-implanted
specimens significantly inhibited the growth of both P. gingi-
valis and A. actinomycetemcomitans (Fig. 19). Fluoride is
widely used as a highly effective anticaries agent. The
principal antibacterial mechanism considered was that a
metal fluoride complex affects bacterial metabolism as an
Table 2 Surface modification of titanium using a cold-plasma technique.
Modification/Treatment Characterization Thickness Hk (10 gf)
Ti-polished TiO2 <30 nm 148 (5)
HAp-coated BDM Hydroxy apatite 1 mm —
Ca-implanted Ion implantation CaTiO3, TiO2, TiO 150 nm 264 (17)
N-implanted TiN, Ti2N, TiO2 300 nm 232 (14)
F-implanted TiF3, TiOF, TiO2 TiO 150 nm 230 (19)
Anode-oxidized Anode oxidation * TiO2 (brookite), TiO 300 nm 227 (25)
Titania-sprayed Frame spraying TiO2 (rutile, anatase) >3 mm —
TiN-coated Ion plating TiN 3 mm 1837 (227)
Alumina-coated Al2O3 (corundum) 3 mm 1355 (66)
Ag-IBM Ion beam mixing Ag, TiO2, TiOx 100 nm 250 (8)
Sn-IBM Sn, TiO2, TiOx 150 nm 212 (6)
Zn-IBM Zn, TiO2, TiOx 100 nm 213 (13)
Pt-IBM Pt, TiO2 150 nm 225 (19)
HMDSO Plasma polymerization CH3, SiO4 100 nm —
O2-plasma Plasma surface treatment C-OH, COOH 10 nm —
N2-plasma C-OH, NH2 10 nm —
IBDM: Ion beam dynamic mixing, HMDSO: hexamethyldisiloxane, *wet process.
98 M. Yoshinari et al.enzyme inhibitor. Incidentally, it was confirmed that F+-
implanted surfaces did not influence the proliferation of
mouse-fibroblast cells. Titania-sprayed specimens generated
no antimicrobial activity despite the anatase that formed on
the surfaces. This may be because no UV light was used, and
no coupling metals were used for stimulating photocatalytic
reactions.
A monoclonal anti-human cystatin-SA (cysteine protease
inhibitor) antibody for cystatin-SA and a histatin5, antimi-
crobial peptides, were immobilized onto those titanium
surfaces. The amounts of adsorbed anti-cystatin and hista-
tin5 were increased by O2 plasma surface modification using a
quartz crystal microbalance (QCM-D) technique, and the0 20 40 60 80 100 120 140
Ti-polished
Ca-implanted
N-implanted
F-implanted
Anode-oxidized
Titania-sprayed
TiN-coated
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Ag-IBM
Sn-IBM
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Percent colony forming unit relative to control
Figure 19 Antimicrobial activity of P. gingivalis on surface-
modified titanium for 48 h (Yoshinari et al. [43]).amount of C. albicans colonization on histatin5-adsorbed
specimens was significantly less than the control [44]
(Fig. 20). There is no significant difference in the amount
of initial attachment of C. albicans among the control
(PMMA), O2-treated PMMA and the histatin5-adsorbed PMMA.
However, the amount of C. albicans biofilm formation on the
histatin5-adsorbed PMMA significantly decreased compared
to that on the other specimens. These results indicate that
histatin5-adsorption does not prevent or reduce adhesion of
the microorganism to the denture surface, but that direct
candidacidal activity of the adsorbed molecules is responsi-
ble for reducing C. albicans biofilm formation on the denture
surface.
Modification of titanium surfaces with conjugated mole-
cules consisting of antimicrobial and hexapeptidic titanium-
binding peptides (minTBP-1) is also useful [45]. Titanium-
binding peptide (minTBP-1) was originally isolated as a 12-Figure 20 Shift in frequency against time for exposure of the
specimen to C. albicans.
(a) Immobilized with histatin-5, (b) control. The SEM images are
also shown in Fig. 20 (Yoshinari et al. [44]).
Table 3 Antimicrobial peptides and conjugated peptides with Ti-binding peptide (minTBP-1).
Classification Amino acid sequence (single letter code) Code
Histatin5 DSHAKRHHGYKRKFHEKHHSHRGY His5
minTBP-1 + Histatin5 RKLPDAPDSHAKRHHGYKRKFHEKHHSHRGY minTBP1+His5
Lactoferricin FQWQRNMRKVR Lfcin
minTBP-1 + Lactoferricin RKLPDAPGGFQWQRNMRKVR minTBP1+Lfcin
Surface modification using cold-plasma technique 99mer peptide, and mutational analyses revealed that the N-
terminal hexapeptide RKLPDA (named minTBP-1) was suffi-
cient for binding (Fig. 21) [46,47]. Mutational studies also
indicated that the first arginine (R1), fourth proline (P4) and
fifth asparate (D5) were important for binding. Because the
surface of titanium is covered with an oxide film displaying
both positively and negatively charged hydroxyl groups under
physiological conditions, electrostatic interactions betweenFigure 21 Schematics of titanium binding peptide (min TBP-1)
(Sano et al. [46,47]).
Figure 22 Shift in frequency (Df) against time for exposure of
Ti sensor to various peptides obtained by QCM-D as a typical
example. At black arrowhead, 100 mg mL1 peptide in PBS-Twas
injected, followed by successive injection of PBS-T (white ar-
rowhead). Decrease in frequency shows mass adsorption on the
surfaces. All experiments except ‘‘Lysozyme w/o blocking’’ were
carried out with the surfactant, i.e. with blocking (Yoshinari
et al. [45]).—O and R1, and —OH2
+ and D5, have been proposed to
underlie the interaction between minTBP-1 and titanium.
Four kinds of peptide were prepared as summarized in Table
3. Adsorption assay of the synthesized peptides was carried
out on crystal quartz sensors coated with Ti using a QCM-D
instrument. The results demonstrated that accretion of sur-
factant reduced nonspecific interactions, dramatically
enhancing the selectivity and specificity of the Ti-binding
peptides, and ensuring reversible specific binding (Fig. 22). In
addition, the bioactivities of P. gingivalis cells on peptide-
modified titanium were evaluated by ATP-bioluminescent
assay. The bioactivity test revealed that ATP activity in P.
gingivalis in peptide-modified specimens significantly
decreased compared to that in the Ti control [45]. These
findings indicate that surface modification with conjugated
molecules consisting of antimicrobial and titanium-binding
peptides is a promising method for reduction of biofilm
formation on titanium implants.
In conclusion, a cold-plasma surface modification is useful
in controlling the physicochemical nature of surfaces, includ-
ing the surface energy and the surface electrical charge,
leading to immobilize the drugs and peptides, and in devel-
oping bio-functional implants (Fig. 4). Considering the pre-
sent technology, it may be possible to produce implants with
highly controlled surfaces that maintain homeostasis.
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